Evidence map›Paper›PMID 40481899›Full record

ArticleClinical and experimental medicine2025

CD44-downregulation in multiple myeloma inhibits cytoskeleton rearrangement through actin depolymerization.

Zhenkui Wang, Yutong Guo, Chun Yang, Hongyan Liang, Jie Zhou, Lei Huang, Yan Xu, Li Xue

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenkui Wang *Department of Neurology, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yutong Guo *Department of Clinical Laboratory, Ordos City Central Hospital, Ordos City, Inner Mongolia, China.
Chun Yang *Department of Clinical Laboratory, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Hongyan LiangDepartment of Clinical Laboratory, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jie ZhouDepartment of Clinical Laboratory, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Lei HuangDepartment of Clinical Laboratory, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yan XuDepartment of Pathology and Lab Medicine, Chinese Academy of Medical Sciences Institute of Hematology and Blood Diseases Hospital, Tianjin, China.
Li XueDepartment of Clinical Laboratory, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China. doctor_xue1980@163.com.

Funding

Excellent youth project of the Fourth Affiliated Hospital of Harbin Medical University NO.HYDSYYXQN202005Project of Heilongjiang Provincial Health Commission No.20220303041084
6 · The paper itself

Abstract

It is well known that multiple myeloma (MM) cells are highly dependent on the bone marrow (BM) microenvironment. However, the complex interactions and signaling pathways between MM cells and BM stromal cells remain inadequately defined. In this study, we employed an in vitro coculture model to investigate these interactions. We found that coculturing MM cells with BM-derived HS5 stromal cells stimulated the secretion of hyaluronic acid (HA) and interleukin-6 (IL-6), and significantly increased the expression of CD44 and F-actin stress fibers polymerization in MM cells. Among the three hyaluronan synthase (HAS) isoforms, HAS3 mRNA expression was most significantly elevated in MM cells following coculture with HS5. This coculture also resulted in upregulation of HAS3 and IL-6 mRNA in MM cells. Notably, MM cells in direct contact with HS5 cells exhibited higher proliferative capacity compared to those not in contact with the stromal cells. Additionally, coculturing MM cells with HS5 led to the formation of membrane protrusions in MM cells, with CD44 enrichment observed at these polarized regions. Further analysis revealed that Rac1 co-localizes with CD44 on MM cells within the coculture system, suggesting that Rac1 signaling plays a critical role in CD44-mediated cytoskeletal rearrangements. Importantly, silencing CD44 expression in MM cells reduced F-actin polymerization, as well as impaired MM cell migration and adhesion to HS5. Our findings highlight the involvement of the HA/CD44/F-actin pathway in MM-BM migration and adhesion, suggesting that CD44 may serve as a novel therapeutic target to disrupt the MM-BM microenvironment.

Indexed as

ActinsCytoskeletonDown-RegulationHyaluronan ReceptorsMultiple MyelomaCell Line, TumorCoculture TechniquesHumansHyaluronan SynthasesHyaluronic AcidInterleukin-6Polymerizationrac1 GTP-Binding ProteinSignal TransductionActinsCD44 protein, humanHyaluronan ReceptorsHyaluronan SynthasesHyaluronic AcidInterleukin-6rac1 GTP-Binding ProteinRAC1 protein, humanCD44F-actinHyaluronic acidInterleukin-6Multiple myeloma cellsStromal cells

Identifiers

PMID40481899
PMCPMC12145313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.